Journal of Cataract & Refractive Surgery
Volume 32, Issue 11 , Pages 1884-1888, November 2006

Direct residual stromal thickness measurement for assessing suitability for LASIK enhancement by Artemis 3D very high-frequency digital ultrasound arc scanning

  • Dan Z. Reinstein, MD, MA(Cantab), FRCSC

      Affiliations

    • Corresponding Author InformationCorresponding author: Dan Z. Reinstein, MD, MA(Cantab), FRCSC, London Vision Clinic, 8 Devonshire Place, London W1G 6HP, United Kingdom.
  • ,
  • Darren G. Couch
  • ,
  • Timothy Archer, Dip Comp Sci(Cantab)

From London Vision Clinic (Reinstein, Couch, Archer) and St. Thomas' Hospital–Kings College (Reinstein), London, United Kingdom; Weill Medical College of Cornell University (Reinstein), New York, New York, USA; and Centre Hospitalier National Ophtalmologie (Reinstein), Paris, France

Accepted 10 August 2006.

We present a patient scheduled for LASIK enhancement based on conventional residual stromal thickness (RST) prediction methods in whom direct measurement of the RST changed the management due to an unexpectedly low RST. The preoperative refraction was −6.00 −0.50 × 115 in the right eye and −6.00 −0.50 × 20 in the left eye. At 9 months, the refractions had regressed to −0.50 −0.50 × 150 and −0.75 −0.25 × 145, respectively. Predicted RST based on preoperative parameters was 283 μm in the right eye and 281 μm in the left eye, sufficient for the planned enhancement. Using the Artemis 3-dimensional very high-frequency digital ultrasound arc scanner, the minimum RST was directly measured as 277 μm in the right eye but only 212 μm in the left eye, which may have significantly increased the risk of iatrogenic ectasia yielding a predicted post-enhancement RST of 253 μm and 192 μm, respectively. The treatment plan was altered as a result of the thinner than predicted RST in the left eye; an enhancement was performed in the right eye only. A second Artemis examination after 22 months found the RST in the left eye to be stable.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Dr. Reinstein has a proprietary interest in the Artemis technology (Ultralink LLC) through patents administered by the Cornell Research Foundation, Ithaca, NY. Dr. Reinstein is a consultant to Carl Zeiss Meditec. None of the other authors has a proprietary or financial interest in the materials presented.Preparation in part fulfillment of the requirements for the doctoral thesis, University of Cambridge, for Dr. Reinstein.

PII: S0886-3350(06)01050-9

doi:10.1016/j.jcrs.2006.08.020

Journal of Cataract & Refractive Surgery
Volume 32, Issue 11 , Pages 1884-1888, November 2006